BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19748175)

  • 1. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy.
    Zhang Q; Shi S; Yen Y; Brown J; Ta JQ; Le AD
    Cancer Lett; 2010 Mar; 289(2):151-60. PubMed ID: 19748175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC).
    Mărgăritescu C; Pirici D; Simionescu C; Stepan A
    Rom J Morphol Embryol; 2011; 52(3 Suppl):985-93. PubMed ID: 22119814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of a subpopulation of CD133
    Ma Z; Zhang C; Liu X; Fang F; Liu S; Liao X; Tao S; Mai H
    Sci Rep; 2020 Jun; 10(1):8875. PubMed ID: 32483269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
    Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
    Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.
    Kubo T; Takigawa N; Osawa M; Harada D; Ninomiya T; Ochi N; Ichihara E; Yamane H; Tanimoto M; Kiura K
    Cancer Sci; 2013 Jan; 104(1):78-84. PubMed ID: 23066953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells.
    Yu CC; Hu FW; Yu CH; Chou MY
    Head Neck; 2016 Apr; 38 Suppl 1():E231-8. PubMed ID: 25545959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.
    Zhang L; Li H; Ge C; Li M; Zhao FY; Hou HL; Zhu MX; Tian H; Zhang LX; Chen TY; Jiang GP; Xie HY; Cui Y; Yao M; Li JJ
    Oncotarget; 2014 Nov; 5(21):10621-35. PubMed ID: 25301737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
    Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
    Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
    World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
    Guo R; Wu Q; Liu F; Wang Y
    Oncol Rep; 2011 Jan; 25(1):141-6. PubMed ID: 21109969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.
    Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J
    Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
    Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
    Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
    Zito G; Richiusa P; Bommarito A; Carissimi E; Russo L; Coppola A; Zerilli M; Rodolico V; Criscimanna A; Amato M; Pizzolanti G; Galluzzo A; Giordano C
    PLoS One; 2008; 3(10):e3544. PubMed ID: 18958156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122.
    Song K; Kwon H; Han C; Zhang J; Dash S; Lim K; Wu T
    Oncotarget; 2015 Dec; 6(38):40822-35. PubMed ID: 26506419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line.
    Nam EJ; Lee M; Yim GW; Kim JH; Kim S; Kim SW; Kim YT
    BMC Med Genomics; 2012 May; 5():18. PubMed ID: 22643117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
    Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
    Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.